ly3023414
Showing 1 - 8 of 8
Endometrial Cancer, Recurrent Endometrial Cancer Trial in United States (LY3023414)
Completed
- Endometrial Cancer
- Recurrent Endometrial Cancer
- LY3023414
-
Basking Ridge, New Jersey
- +5 more
Sep 13, 2022
Prostate Cancer Metastatic Trial in United States (LY3023414, Enzalutamide, Placebo)
Completed
- Prostate Cancer Metastatic
- LY3023414
- +2 more
-
Homewood, Alabama
- +35 more
Apr 17, 2021
Carcinoma, Non-small Cell Lung Trial in Spain, United States (Abemaciclib, Pemetrexed, Gemcitabine)
Completed
- Carcinoma, Non-small Cell Lung
- Abemaciclib
- +5 more
-
Fayetteville, Arkansas
- +10 more
Aug 22, 2020
Tumor Trial in Chiba, Tokyo (LY3023414)
Completed
- Neoplasm
- LY3023414
-
Chiba, Japan
- +1 more
Jul 20, 2018
Pancreatic Ductal Adenocarcinoma Trial in Worldwide (Abemaciclib, LY3023414, Gemcitabine)
Completed
- Pancreatic Ductal Adenocarcinoma
- Abemaciclib
- +3 more
-
New Haven, Connecticut
- +31 more
Nov 6, 2019